Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

FDA Approves Neoadjuvant/Adjuvant Nivolumab for Resectable Non-Small Cell Lung Cancer

Ogkologos - 15 Οκτωβρίου, 2024

EMA Recommends Extension of Therapeutic Indications for Daratumumab

Ogkologos - 14 Οκτωβρίου, 2024

Molecular Analysis for Precision Oncology Congress 2024 London, UK, 16-18 October

Ogkologos - 14 Οκτωβρίου, 2024

Colorectal Cancer Screening: Where Does the Shield Liquid Biopsy Fit In?

Ogkologos - 11 Οκτωβρίου, 2024

Pembrolizumab Plus Chemoradiotherapy Significantly Improves OS in Patients with Locally Advanced...

Ogkologos - 11 Οκτωβρίου, 2024

10-Year Data Underscore How ICI Therapy Has Helped to Change the...

Ogkologos - 10 Οκτωβρίου, 2024

Efficacy of Tivozanib Monotherapy in the Post-ICI Setting Among Patients with...

Ogkologos - 9 Οκτωβρίου, 2024

FDA Approves Osimertinib for Locally Advanced, Unresectable Stage III Non-Small Cell...

Ogkologos - 8 Οκτωβρίου, 2024

EMA Recommends Additional Extensions of Indications for Pembrolizumab

Ogkologos - 7 Οκτωβρίου, 2024

Some Women Avoid Breast Cancer Screening After False-Positive Mammogram Results

Ogkologos - 4 Οκτωβρίου, 2024

1...676869...440 Σελίδα 68 από 440

MOST POPULAR

EMA Recommends Extension of Indications for Darolutamide

31 Ιανουαρίου, 2023

EMA Recommends Granting a Marketing Authorisation for Elinzanetant

26 Σεπτεμβρίου, 2025

Rationale Explained for Granting EMA Authorisation for Extended Use of Nivolumab...

18 Νοεμβρίου, 2020

Getting cancer services back on track during the COVID-19 pandemic

22 Ιουνίου, 2020

Φόρτωση περισσοτέρων

FDA Approves Neoadjuvant/Adjuvant Nivolumab for Resectable Non-Small Cell Lung Cancer

EMA Recommends Extension of Therapeutic Indications for Daratumumab

Molecular Analysis for Precision Oncology Congress 2024 London, UK, 16-18 October

Colorectal Cancer Screening: Where Does the Shield Liquid Biopsy Fit In?

Pembrolizumab Plus Chemoradiotherapy Significantly Improves OS in Patients with Locally Advanced...

10-Year Data Underscore How ICI Therapy Has Helped to Change the...

Efficacy of Tivozanib Monotherapy in the Post-ICI Setting Among Patients with...

FDA Approves Osimertinib for Locally Advanced, Unresectable Stage III Non-Small Cell...

EMA Recommends Additional Extensions of Indications for Pembrolizumab

Some Women Avoid Breast Cancer Screening After False-Positive Mammogram Results

MOST POPULAR

EMA Recommends Extension of Indications for Darolutamide

EMA Recommends Granting a Marketing Authorisation for Elinzanetant

Rationale Explained for Granting EMA Authorisation for Extended Use of Nivolumab...

Getting cancer services back on track during the COVID-19 pandemic

HOT NEWS

Bowel Cancer Data Reinforce Need to Reduce Unnecessary Antibiotic Use [ESMO...

Lutathera Shows Promise as Part of Initial Therapy for Some Neuroendocrine...

Young Mom Of Two Survived Breast Cancer, Heart Failure, And Two...

Latest episode of our podcast for researchers

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ